These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22156850)

  • 21. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada.
    Brousseau N; Skowronski DM; Bellemare D; Amini R; Joffres Y; Clarke Q; Quach C; Rallu F; Hoang L; De Serres G
    Vaccine; 2020 Jan; 38(3):427-432. PubMed ID: 31685295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination.
    Kolos V; Menzies R; McIntyre P
    Vaccine; 2007 Jan; 25(4):588-90. PubMed ID: 16971026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pertussis vaccination strategies for neonates--an exploratory cost-effectiveness analysis.
    Scuffham PA; McIntyre PB
    Vaccine; 2004 Jul; 22(21-22):2953-64. PubMed ID: 15246632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pertussis immunization within three adult populations concerned by cocoon strategy in Île-de-France].
    Lempereur de Guerny MC; Scauflaire M; Crabot D; Le Cossec C; Partouche H
    Rev Epidemiol Sante Publique; 2017 Nov; 65(6):389-395. PubMed ID: 29089164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of pre-school booster vaccination of 4--6-year-old children on pertussis in 0--1-year-old children.
    Hviid A; Stellfeld M; Wohlfahrt J; Andersen PH; Melbye M
    Vaccine; 2006 Feb; 24(9):1401-7. PubMed ID: 16207504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Free vaccine programs to cocoon high-risk infants and children against influenza and pertussis.
    Guzman-Cottrill JA; Phillipi CA; Dolan SA; Nyquist AC; Win A; Siegel J
    Am J Infect Control; 2012 Nov; 40(9):872-6. PubMed ID: 23116758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pertussis in the Netherlands].
    de Greeff SC; de Melker HE; Mooi FR
    Ned Tijdschr Geneeskd; 2010; 154():A1383. PubMed ID: 20170575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada.
    Mikelova LK; Halperin SA; Scheifele D; Smith B; Ford-Jones E; Vaudry W; Jadavji T; Law B; Moore D;
    J Pediatr; 2003 Nov; 143(5):576-81. PubMed ID: 14615725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pertussis: still a cause of death, seven decades into vaccination.
    Jakinovich A; Sood SK
    Curr Opin Pediatr; 2014 Oct; 26(5):597-604. PubMed ID: 25136948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993.
    Wortis N; Strebel PM; Wharton M; Bardenheier B; Hardy IR
    Pediatrics; 1996 May; 97(5):607-12. PubMed ID: 8628595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of maternal dTpa vaccination on the incidence of pertussis in young infants.
    Friedrich F; Valadão MC; Brum M; Comaru T; Pitrez PM; Jones MH; Pinto LA; Scotta MC
    PLoS One; 2020; 15(1):e0228022. PubMed ID: 31990945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Whooping cough in The Netherlands, 1989-1994].
    de Melker HE; Conyn-van Spaendonck MA; Rümke HC; Sprenger MJ; Schellekens JF
    Ned Tijdschr Geneeskd; 1995 Jun; 139(25):1280-6. PubMed ID: 7609803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for the administration of acellular pertussis vaccine to parents of infants in the neonatal intensive care unit.
    Shah S; Caprio M; Mally P; Hendricks-Munoz K
    J Perinatol; 2007 Jan; 27(1):1-3. PubMed ID: 17180125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine.
    Rendi-Wagner P; Kundi M; Mikolasek A; Vécsei A; Frühwirth M; Kollaritsch H
    Vaccine; 2006 Aug; 24(33-34):5960-5. PubMed ID: 16757063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using computer simulations to compare pertussis vaccination strategies in Australia.
    Hethcote HW; Horby P; McIntyre P
    Vaccine; 2004 Jun; 22(17-18):2181-91. PubMed ID: 15149775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of routine vaccination with a pertussis toxoid vaccine in Denmark.
    Hviid A; Stellfeld M; Andersen PH; Wohlfahrt J; Melbye M
    Vaccine; 2004 Sep; 22(27-28):3530-4. PubMed ID: 15315832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative.
    Forsyth KD; Campins-Marti M; Caro J; Cherry JD; Greenberg D; Guiso N; Heininger U; Schellekens J; Tan T; von König CH; Plotkin S;
    Clin Infect Dis; 2004 Dec; 39(12):1802-9. PubMed ID: 15578403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Problems of whooping cough not yet solved. Epidemiology and vaccination strategy in Germany--country-wide field study].
    Schneeweiss B; Swidsinski S
    Fortschr Med; 1997 Aug; 115(24):28-30. PubMed ID: 9410816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.